TGTX — TG THERAPEUTICS INC

Ownership history in nVerses Capital, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which nVerses Capital, LLC reported a position in TG THERAPEUTICS INC (TGTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.56% (2025 Q4)
Avg. % of fund
0.26%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 8,392 +2,592 +44.7% 0.56% $250K $29.81
2024 Q2 ADDED 5,800 +1,500 +34.9% 0.06% $103K $17.79
2024 Q1 INITIATED 4,300 — — 0.16% $65K —
% of Fund (quarterly)    TGTX price (monthly, adj. close)

Other funds also holding TGTX

As of 2025 Q4 — sorted by position size

M28 Capital Management LP 3Y 3.5% Soleus Capital Management, L.P. 3Y 3.45% Opaleye Management Inc. 3Y 7Y 2.1% Pandora Wealth, Inc. 1.41% Penn Capital Management Company, LLC 3Y 7Y 1.28% Quantum Private Wealth, LLC 3Y 0.86% IRIDIAN ASSET MANAGEMENT LLC/CT 3Y 7Y 0.83% Knott David M Jr 3Y 0.62% Hood River Capital Management LLC 3Y 7Y 0.52% 683 Capital Management, LLC 3Y 7Y 0.47%
← Back to nVerses Capital, LLC Holdings